157 related articles for article (PubMed ID: 16736721)
1. The role of chemotherapy in the treatment of malignant astrocytomas.
Mathieu D; Fortin D
Can J Neurol Sci; 2006 May; 33(2):127-40. PubMed ID: 16736721
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy and delivery in the treatment of primary brain tumors.
Mathieu D; Fortin D
Curr Clin Pharmacol; 2007 Sep; 2(3):197-211. PubMed ID: 18690866
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article.
Koukourakis GV; Kouloulias V; Zacharias G; Papadimitriou C; Pantelakos P; Maravelis G; Fotineas A; Beli I; Chaldeopoulos D; Kouvaris J
Molecules; 2009 Apr; 14(4):1561-77. PubMed ID: 19384285
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide. A new option for high-grade astrocytomas.
Schwenka J; Ignoffo RJ
Cancer Pract; 2000; 8(6):311-3. PubMed ID: 11898150
[No Abstract] [Full Text] [Related]
5. [Glioma therapy up-date].
de la Fuente BP; Dalmau J; Rosenfeld M
Neurologia; 2007 Apr; 22(3):159-69. PubMed ID: 17364254
[TBL] [Abstract][Full Text] [Related]
6. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; Quiñones-Hinojosa AR
J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
[TBL] [Abstract][Full Text] [Related]
7. Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma?
Siker ML; Chakravarti A; Mehta MP
Crit Rev Oncol Hematol; 2006 Nov; 60(2):99-111. PubMed ID: 17027279
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide and treatment of malignant glioma.
Friedman HS; Kerby T; Calvert H
Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
[TBL] [Abstract][Full Text] [Related]
9. Treatment of astrocytomas.
Gonzalez J; Gilbert MR
Curr Opin Neurol; 2005 Dec; 18(6):632-8. PubMed ID: 16280673
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide.
Levin N; Gomori JM; Siegal T
Neurology; 2004 Jul; 63(2):354-6. PubMed ID: 15277636
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
Sipos L; Vitanovics D; Afra D
Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors.
Combs SE; Nagy M; Edler L; Rausch R; Bischof M; Welzel T; Debus J; Schulz-Ertner D
Radiother Oncol; 2008 Aug; 88(2):177-82. PubMed ID: 18395280
[TBL] [Abstract][Full Text] [Related]
13. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.
Wick W; Platten M; Meisner C; Felsberg J; Tabatabai G; Simon M; Nikkhah G; Papsdorf K; Steinbach JP; Sabel M; Combs SE; Vesper J; Braun C; Meixensberger J; Ketter R; Mayer-Steinacker R; Reifenberger G; Weller M;
Lancet Oncol; 2012 Jul; 13(7):707-15. PubMed ID: 22578793
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
15. Initial chemotherapy in gliomatosis cerebri.
Sanson M; Cartalat-Carel S; Taillibert S; Napolitano M; Djafari L; Cougnard J; Gervais H; Laigle F; Carpentier A; Mokhtari K; Taillandier L; Chinot O; Duffau H; Honnorat J; Hoang-Xuan K; Delattre JY;
Neurology; 2004 Jul; 63(2):270-5. PubMed ID: 15277619
[TBL] [Abstract][Full Text] [Related]
16. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
[TBL] [Abstract][Full Text] [Related]
17. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas.
Fukushima T; Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Soma G
Anticancer Res; 2003; 23(6a):4473-81. PubMed ID: 14666736
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic strategies for the management of gliomas].
Hottinger AF; Stupp R
Rev Neurol (Paris); 2008; 164(6-7):523-30. PubMed ID: 18565350
[TBL] [Abstract][Full Text] [Related]
19. A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme.
Limentani SA; Asher A; Heafner M; Kim JW; Fraser R
J Neurooncol; 2005 May; 72(3):241-4. PubMed ID: 15937647
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide for refractory anaplastic astrocytoma.
Med Lett Drugs Ther; 1999 Dec; 41(1068):123-4. PubMed ID: 10987014
[No Abstract] [Full Text] [Related]
[Next] [New Search]
